Correlation Between Actinogen Medical and EROAD

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Actinogen Medical and EROAD at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Actinogen Medical and EROAD into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Actinogen Medical and EROAD, you can compare the effects of market volatilities on Actinogen Medical and EROAD and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Actinogen Medical with a short position of EROAD. Check out your portfolio center. Please also check ongoing floating volatility patterns of Actinogen Medical and EROAD.

Diversification Opportunities for Actinogen Medical and EROAD

0.68
  Correlation Coefficient

Poor diversification

The 3 months correlation between Actinogen and EROAD is 0.68. Overlapping area represents the amount of risk that can be diversified away by holding Actinogen Medical and EROAD in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on EROAD and Actinogen Medical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Actinogen Medical are associated (or correlated) with EROAD. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of EROAD has no effect on the direction of Actinogen Medical i.e., Actinogen Medical and EROAD go up and down completely randomly.

Pair Corralation between Actinogen Medical and EROAD

Assuming the 90 days trading horizon Actinogen Medical is expected to generate 2.17 times more return on investment than EROAD. However, Actinogen Medical is 2.17 times more volatile than EROAD. It trades about 0.06 of its potential returns per unit of risk. EROAD is currently generating about 0.09 per unit of risk. If you would invest  2.50  in Actinogen Medical on August 31, 2024 and sell it today you would earn a total of  0.10  from holding Actinogen Medical or generate 4.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Actinogen Medical  vs.  EROAD

 Performance 
       Timeline  
Actinogen Medical 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Actinogen Medical has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in December 2024. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.
EROAD 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days EROAD has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's fundamental indicators remain comparatively stable which may send shares a bit higher in December 2024. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Actinogen Medical and EROAD Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Actinogen Medical and EROAD

The main advantage of trading using opposite Actinogen Medical and EROAD positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Actinogen Medical position performs unexpectedly, EROAD can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in EROAD will offset losses from the drop in EROAD's long position.
The idea behind Actinogen Medical and EROAD pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.

Other Complementary Tools

Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
CEOs Directory
Screen CEOs from public companies around the world
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk